Bangalore, India-- (SBWIRE) -- 09/15/2016 -- NIPT is an advanced technology that helps detect fatal chromosomal aneuploidies by analyzing the fetus' cell-free DNA. It also helps diagnose the risks for genetic disorders such as Down, Turner, Klinefelter, and XYY syndromes, which are common sex chromosomal aneuploidies associated with reproductive loss, infertility, and language development delays. Since its introduction into clinical practice in Hong Kong in 2011, NIPT has rapidly spread across the world.

Report forecast the global non-invasive prenatal testing (NIPT) market to grow at a CAGR of 17.44% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the global non-invasive prenatal testing (NIPT) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of testing products.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Global Non-Invasive Prenatal Testing (NIPT) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- BGI Genomics
- Illumina
- LifeCodexx
- Natera
- Sequenom

Other prominent vendors
- Ariosa Diagnostics
- Berry Genomics
- CombiMatrix
- F. Hoffmann-La Roche
- Genpharm Services
- Laboratory Corporation of America Holdings
- LifeLabs Genetics
- Quest Diagnostics
- Safembryo
- Sengenics

Market driver
- Incidence of fetal chromosomal disorders in newborns
- For a full, detailed list, view our report

Market challenge
- Limited consumer options and lack of effective product differentiation
- For a full, detailed list, view our report

Market trend
- Increase in partnerships and collaborations
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 70 pages "Global Non-Invasive Prenatal Testing Market 2016-2020" report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market landscape, Market segmentation by testing product, Market segmentation by end-user, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Major vendors, Appendix.

For more information Visit at: http://www.drugpipeline.net/technavio/global-non-invasive-prenatal-testing-market-2016-2020

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.